Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Always Active
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.

Why drug resistance is becoming one of our biggest global health security blind-spots

24 January 2024

Logo Wef Dark

 

24 January 2024

A recent wave of increased hospitalizations for respiratory infections in Northern China is the result of Mycoplasma pneumoniae, a bacterial infection that is usually mild and affects children and young adults causing respiratory symptoms or, in some cases, mild pneumonia.

But this shouldn’t come as a surprise. Not just because a surge of respiratory infections had been anticipated in China following the relaxing of strict COVID-19-related restrictions but also because previous levels of drug resistance to M. pneumonia, as high as 90%, have been reported in Beijing.

 

Read the article